A carregar...
An Opportunistic Infection Associated With Ruxolitinib, a Novel Janus Kinase 1,2 Inhibitor
We report a case of Cryptococcus neoformans pneumonia in a patient taking ruxolitinib, a janus kinase 1,2 inhibitor approved for the treatment of myelofibrosis. We hypothesize that ruxolitinib contributed to this infection through its effects on cell-mediated immunity. Clinicians should be aware of...
Na minha lista:
| Publicado no: | Chest |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American College of Chest Physicians
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5991580/ https://ncbi.nlm.nih.gov/pubmed/23648912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.12-1604 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|